• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调控芳基脒类药物抑制利什曼原虫的分子因素:改进化疗的保守计算建模。

Molecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.

机构信息

Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA.

出版信息

Bioorg Med Chem. 2011 Aug 1;19(15):4552-61. doi: 10.1016/j.bmc.2011.06.026. Epub 2011 Jun 16.

DOI:10.1016/j.bmc.2011.06.026
PMID:21741248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3164838/
Abstract

A dataset of 55 compounds with inhibitory activity against Leishmania donovani axenic amastigotes and Leishmania amazonensis intracellular parasites was examined through three-dimensional quantitative structure-activity relationship modeling employing molecular descriptors from both rigid and flexible compound alignments. For training and testing purposes, the compounds were divided into two datasets of 45 and 10 compounds, respectively. Statistically significant models were constructed and validated via the internal and external predictions. For all models employing steric, electrostatic, hydrophobic, H-donor and H-acceptor molecular descriptors, the R² values were greater than 0.90 and the SEE values were less than 0.22. The models obtained from rigid and flexible compounds were employed together to obtain a conservative method for predictions. This method minimized under predictions. Molecular descriptors from the models were then extrapolated, for the overall predictive devices and the individual compounds, and examined with regard to inhibitory activity. Information gained from the molecular descriptors is useful in the design of novel compounds. The models obtained can be employed to predict activities of the compounds designed and/or form predictions for compounds that exist and have not yet been examined with biological inhibitory assays.

摘要

研究了一个包含 55 种化合物的数据集,这些化合物对利什曼原虫无鞭毛体和利什曼原虫内寄生虫具有抑制活性,通过使用刚性和柔性化合物排列的分子描述符进行三维定量构效关系建模进行了检查。为了培训和测试目的,将化合物分别分为 45 种和 10 种化合物的两个数据集。通过内部和外部预测构建和验证了具有统计学意义的模型。对于所有使用立体、静电、疏水、H 供体和 H 受体分子描述符的模型,R²值均大于 0.90,SEE 值均小于 0.22。将来自刚性和柔性化合物的模型一起用于获得一种保守的预测方法。该方法最小化了预测不足。然后对整体预测设备和个别化合物进行了从模型中得出的分子描述符的外推,并根据抑制活性对其进行了检查。从分子描述符中获得的信息可用于设计新型化合物。获得的模型可用于预测设计化合物的活性和/或对存在但尚未用生物抑制测定法进行检查的化合物进行预测。

相似文献

1
Molecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.调控芳基脒类药物抑制利什曼原虫的分子因素:改进化疗的保守计算建模。
Bioorg Med Chem. 2011 Aug 1;19(15):4552-61. doi: 10.1016/j.bmc.2011.06.026. Epub 2011 Jun 16.
2
Novel arylimidamides for treatment of visceral leishmaniasis.新型芳基脒类药物治疗内脏利什曼病。
Antimicrob Agents Chemother. 2010 Jun;54(6):2507-16. doi: 10.1128/AAC.00250-10. Epub 2010 Apr 5.
3
Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.单芳基咪唑酰胺类抗利什曼原虫药物的合成与药理学评价
Bioorg Med Chem Lett. 2016 May 15;26(10):2551-2556. doi: 10.1016/j.bmcl.2016.03.082. Epub 2016 Mar 25.
4
The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.白花丹醌及其他电子载体对杜氏利什曼原虫和亚马逊墨西哥利什曼原虫的活性。
Ann Trop Med Parasitol. 1985 Dec;79(6):651-3. doi: 10.1080/00034983.1985.11811974.
5
Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening.通过比较表型筛选发现对内脏和皮肤利什曼原虫种具有广泛活性的新型命中化合物。
Sci Rep. 2019 Jan 24;9(1):438. doi: 10.1038/s41598-018-36944-6.
6
Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivatives.(4-芳基哌嗪-1-基)(1-(噻吩-2-基)-9H-吡啶并[3,4-b]吲哚-3-基)甲酮衍生物的合成及体外抗利什曼原虫活性。
Bioorg Chem. 2017 Feb;70:100-106. doi: 10.1016/j.bioorg.2016.11.013. Epub 2016 Dec 2.
7
Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.合成及三氟拉林类似物的生物评价作为抗利什曼原虫药物。
Bioorg Med Chem. 2010 Jan 1;18(1):274-81. doi: 10.1016/j.bmc.2009.10.059. Epub 2009 Oct 31.
8
QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.新型抗利什曼原虫二芳基硫化物和磺胺类化合物的定量构效关系和对接研究。
Eur J Med Chem. 2010 Nov;45(11):4879-89. doi: 10.1016/j.ejmech.2010.07.060. Epub 2010 Aug 7.
9
effect of alpha-bisabolol and its synthetic derivatives on macrophages, promastigotes, and amastigotes of and .α-红没药醇及其合成衍生物对[具体物种名称]的巨噬细胞、前鞭毛体和无鞭毛体的影响。 (注:原文中“and.”表述不完整,推测可能是遗漏了某些物种相关信息)
Nat Prod Res. 2025 Feb;39(4):1004-1009. doi: 10.1080/14786419.2023.2288232. Epub 2023 Nov 27.
10
Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture.疟疾药物病原体框化合物中的生长抑制剂。
Drug Des Devel Ther. 2020 Mar 31;14:1307-1317. doi: 10.2147/DDDT.S244903. eCollection 2020.

引用本文的文献

1
Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years.皮肤利什曼病的药物研发:过去15年进展综述
Microorganisms. 2023 Nov 23;11(12):2845. doi: 10.3390/microorganisms11122845.
2
Synthesis and Biophysical and Biological Studies of -Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites.合成及含苯甲酰胺衍生物的生物物理和生物学研究,针对原生动物寄生虫。
J Med Chem. 2023 Oct 12;66(19):13452-13480. doi: 10.1021/acs.jmedchem.3c00697. Epub 2023 Sep 20.
3
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl Linker.含苯氧烷基连接物的芳基酰亚胺-唑类杂合体的合成及抗利什曼原虫活性评价。
ACS Infect Dis. 2021 Jul 9;7(7):1901-1922. doi: 10.1021/acsinfecdis.0c00855. Epub 2021 Feb 4.
4
Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations.DB766-唑类联合的抗利什曼原虫疗效和药代动力学。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01129-17. Print 2018 Jan.
5
Structure-dependent binding of arylimidamides to the DNA minor groove.芳基脒类与 DNA 小沟的结构依赖性结合。
Chembiochem. 2014 Jan 3;15(1):68-79. doi: 10.1002/cbic.201300622. Epub 2013 Dec 9.
6
Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.新型脒类及其类似物作为有前途的抗细胞内寄生虫药物:系统评价。
Parasitology. 2013 Jul;140(8):929-51. doi: 10.1017/S0031182013000292. Epub 2013 Apr 8.
7
Synthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides.双芳基脒低分子量化合物的合成、DNA 结合及抗利什曼原虫活性。
Eur J Med Chem. 2012 Sep;55:449-54. doi: 10.1016/j.ejmech.2012.06.058. Epub 2012 Jul 14.
8
Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studies.评估芳基脒类化合物 DB1955 和 DB1960 作为内脏利什曼病和恰加斯病候选药物的研究:体内疗效、急性毒性、药代动力学和毒理学研究。
Antimicrob Agents Chemother. 2012 Jul;56(7):3690-9. doi: 10.1128/AAC.06404-11. Epub 2012 Apr 16.

本文引用的文献

1
Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.脂质体两性霉素 B 治疗皮肤利什曼病。
Am J Trop Med Hyg. 2010 Nov;83(5):1028-33. doi: 10.4269/ajtmh.2010.10-0171.
2
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.印度次大陆内脏利什曼病联合疗法的成本效益分析。
PLoS Negl Trop Dis. 2010 Sep 7;4(9):e818. doi: 10.1371/journal.pntd.0000818.
3
Designing and reporting clinical trials on treatments for cutaneous leishmaniasis.设计和报告治疗皮肤利什曼病的临床试验。
Clin Infect Dis. 2010 Aug 15;51(4):409-19. doi: 10.1086/655134.
4
Treatment of visceral leishmaniasis.内脏利什曼病的治疗。
J Glob Infect Dis. 2010 May;2(2):151-8. doi: 10.4103/0974-777X.62883.
5
Novel arylimidamides for treatment of visceral leishmaniasis.新型芳基脒类药物治疗内脏利什曼病。
Antimicrob Agents Chemother. 2010 Jun;54(6):2507-16. doi: 10.1128/AAC.00250-10. Epub 2010 Apr 5.
6
Combination therapy for visceral leishmaniasis.内脏利什曼病的联合治疗。
Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6.
7
Trypanosomatid parasites causing neglected diseases.引起被忽视疾病的锥体虫寄生虫。
Curr Med Chem. 2010;17(15):1594-617. doi: 10.2174/092986710790979953.
8
Single-dose liposomal amphotericin B for visceral leishmaniasis in India.印度单剂量脂质体两性霉素 B 治疗内脏利什曼病。
N Engl J Med. 2010 Feb 11;362(6):504-12. doi: 10.1056/NEJMoa0903627.
9
Tropical medicine rounds: Treatment of Old World cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination.热带医学巡诊:氨苯砜、伊曲康唑、冷冻疗法和咪喹莫特单独及联合治疗东半球皮肤利什曼病
Int J Dermatol. 2009 Aug;48(8):862-9. doi: 10.1111/j.1365-4632.2008.04010.x.
10
Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.印度内脏利什曼病的短疗程巴龙霉素治疗:14天与21天治疗对比
Clin Infect Dis. 2009 Sep 15;49(6):914-8. doi: 10.1086/605438.